Tadalafil, a phosphodiesterase type 5 inhibitor, improves bladder blood supply and restores the initial phase of lower urinary tract dysfunction in diabetic rats

Daisuke Gotoh; Kazumasa Torimoto; Yoshihiro Tatsumi; Shunta Hori; Atsushi Yamada; Makito Miyake; Yosuke Morizawa; Katsuya Aoki; Nobumichi Tanaka; Akihide Hirayama; Kiyohide Fujimoto

doi:10.1002/nau.23372

Tadalafil, a phosphodiesterase type 5 inhibitor, improves bladder blood supply and restores the initial phase of lower urinary tract dysfunction in diabetic rats

Neurourology and Urodynamics ◽

10.1002/nau.23372 ◽

2017 ◽

Vol 37 (2) ◽

pp. 666-672 ◽

Cited By ~ 10

Author(s):

Daisuke Gotoh ◽

Kazumasa Torimoto ◽

Yoshihiro Tatsumi ◽

Shunta Hori ◽

Atsushi Yamada ◽

...

Keyword(s):

Urinary Tract ◽

Blood Supply ◽

Initial Phase ◽

Lower Urinary Tract ◽

Diabetic Rats ◽

Lower Urinary Tract Dysfunction ◽

Phosphodiesterase Type 5 Inhibitor ◽

Phosphodiesterase Type ◽

Lower Urinary

Download Full-text

Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis

World Journal of Urology ◽

10.1007/s00345-018-2370-z ◽

2018 ◽

Vol 37 (1) ◽

pp. 143-153 ◽

Cited By ~ 7

Author(s):

Jianzhong Zhang ◽

Xiao Li ◽

Bin Yang ◽

Cheng Wu ◽

Yanghua Fan ◽

...

Keyword(s):

Systematic Review ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Meta Analysis ◽

Prostatic Hyperplasia ◽

Alpha Blockers ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Lower Urinary

Download Full-text

Role of Phosphodiesterase Type 5 Inhibitor on Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms

Korean Journal of Andrology ◽

10.5534/kja.2011.29.2.91 ◽

2011 ◽

Vol 29 (2) ◽

pp. 91 ◽

Cited By ~ 1

Author(s):

Sang Deuk Kim ◽

Jong Kwan Park

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Lower Urinary

Download Full-text

Re: A Placebo-Controlled Study Investigating the Efficacy and Safety of the Phosphodiesterase Type 5 Inhibitor UK-369,003 for the Treatment of Men With Lower Urinary Tract Symptoms Associated With Clinical Benign Prostatic Hyperplasia

The Journal of Urology ◽

10.1016/j.juro.2011.09.107 ◽

2012 ◽

Vol 187 (1) ◽

pp. 213-214

Author(s):

Steven A. Kaplan

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Efficacy And Safety ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Lower Urinary

Download Full-text

A placebo-controlled exploratory study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with storage lower urinary tract symptoms associated with a clinical diagnosis of overactive bladder

BJU International ◽

10.1111/j.1464-410x.2010.09205.x ◽

2010 ◽

Vol 106 (5) ◽

pp. 666-673 ◽

Cited By ~ 19

Author(s):

Francois A. Giuliano ◽

Janice Lamb ◽

Anna Crossland ◽

Scott Haughie ◽

Peter Ellis ◽

...

Keyword(s):

Urinary Tract ◽

Overactive Bladder ◽

Clinical Diagnosis ◽

Exploratory Study ◽

Lower Urinary Tract ◽

Efficacy And Safety ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Lower Urinary

Download Full-text

EFFECT OF PHOSPHODIESTERASE TYPE 5 INHIBITOR (PDE5I) USE ON LOWER URINARY TRACT SYMPTOMS (LUTS) OVER TIME AMONG MEN ON WATCHFUL WAITING VERSUS BPH MEDICAL THERAPY: RESULTS FROM THE BPH REGISTRY

The Journal of Urology ◽

10.1016/s0022-5347(09)61817-6 ◽

2009 ◽

Vol 181 (4) ◽

pp. 648

Author(s):

Allen D. Seftel ◽

John T Wei ◽

Raymond C. Rosen ◽

David J. Pasta ◽

Martin Miner ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract Symptoms ◽

Medical Therapy ◽

Lower Urinary Tract ◽

Watchful Waiting ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Over Time ◽

Lower Urinary

Download Full-text

Continuing Medical Education: 2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 1: Recent Studies on Routine Dosing for Penile Rehabilitation, Lower Urinary Tract Symptoms, and Other Indications (CME)

Journal of Sexual Medicine ◽

10.1111/j.1743-6109.2009.01347.x ◽

2009 ◽

Vol 6 (7) ◽

pp. 1794-1808 ◽

Cited By ~ 35

Author(s):

Alan W. Shindel

Keyword(s):

Medical Education ◽

Urinary Tract ◽

Lower Urinary Tract Symptoms ◽

Continuing Medical Education ◽

Lower Urinary Tract ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Penile Rehabilitation ◽

Lower Urinary

Download Full-text

Impact of postoperative phosphodiesterase type 5 inhibitor treatment on lower urinary tract symptoms after robot-assisted radical prostatectomy: a longitudinal study

Scandinavian Journal of Urology ◽

10.1080/21681805.2016.1250810 ◽

2016 ◽

Vol 51 (1) ◽

pp. 33-37 ◽

Cited By ~ 5

Author(s):

Masashi Honda ◽

Bunya Kawamoto ◽

Shuichi Morizane ◽

Katsuya Hikita ◽

Kuniyasu Muraoka ◽

...

Keyword(s):

Longitudinal Study ◽

Urinary Tract ◽

Radical Prostatectomy ◽

Lower Urinary Tract ◽

Robot Assisted ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Inhibitor Treatment ◽

Lower Urinary

Download Full-text

A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia

BJU International ◽

10.1111/j.1464-410x.2010.09204.x ◽

2010 ◽

Vol 106 (5) ◽

pp. 674-680 ◽

Cited By ~ 35

Author(s):

Nihad A.M. Tamimi ◽

Ivan Mincik ◽

Scott Haughie ◽

Janice Lamb ◽

Anna Crossland ◽

...

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Controlled Study ◽

Efficacy And Safety ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Lower Urinary

Download Full-text

Re: Alpha-Blockers with or without Phosphodiesterase Type 5 Inhibitor for Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis

The Journal of Urology ◽

10.1097/01.ju.0000614748.55702.9c ◽

2020 ◽

Vol 203 (2) ◽

pp. 227-228

Author(s):

Steven A. Kaplan

Keyword(s):

Systematic Review ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Meta Analysis ◽

Prostatic Hyperplasia ◽

Alpha Blockers ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Lower Urinary

Download Full-text

Phosphodiesterase Type 5 Inhibitor and Erectile Dysfunction in Lower Urinary Tract Symptoms

LUTS Lower Urinary Tract Symptoms ◽

10.1111/j.1757-5672.2011.00121.x ◽

2012 ◽

Vol 4 ◽

pp. 75-80

Author(s):

Chen ZHAO ◽

Jong KWAN PARK

Keyword(s):

Erectile Dysfunction ◽

Urinary Tract ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Phosphodiesterase Type 5 Inhibitor ◽

Urinary Tract Symptoms ◽

Phosphodiesterase Type ◽

Lower Urinary

Download Full-text